Stock Events

Stock Events

Relmada Therapeutics (4E2.F) Q3 2025 Earnings

7AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.67

-0.53

-0.39

-0.26

Details

Expected EPS

-0.3939072

Actual EPS

-0.25689599999999996

Surprise EPS

0.14

Surprise Percent

+34.78%

Description

Relmada Therapeutics (4E2.F) has reported earnings of -0.25689599999999996 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.